RandyW Posted January 15, 2010 Share Posted January 15, 2010 A New Zealand medicine for lung cancer, which works by disrupting the blood vessels which are within the tumor, thereby inhibiting the blood flow, seems to reflect promising results, as has been shared by researchers who are expected to reported their findings at a cancer meeting scheduled to take place in California tomorrow. The new medicine, discovered and developed at the Auckland University and named vadimezan, when given in combination with chemotherapy, managed to extend the survival time, confirmed Associate Professor Mark McKeage, a specialist in clinical pharmacology at theuniversity. "Overall survival was improved numerically from a median of 8.8 to 14 months. he safety profile is favorable", he said. The results have come after extensive studies conducted on patients suffering from advanced non-small-cell lung cancer. The results will now be presented by Professor McKeage at the meeting "American Association for Cancer Research-International Association for the Study ofLung Cancer" in Coronado, California. The drug has been discovered by Bruce Baguley and William Denny, professors at the Auckland University. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.